Intermediate Risk

• PSA 10-20
• Gleason 3+4 or 4+3
• Clinical Exam: Abnormality that does not extend beyond the boundary of the prostate

Management Options

---

• Open Radical Prostatectomy
• Robotic Radical Prostatectomy
• Radiation Therapy
• Watchful Waiting

Clinical Trials

---

• Find National Cancer Institute-Supported Clinical Trials for Intermediate Risk Prostate Cancer